Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Clinical trial NCT05195918 · COMPLETED

Trial details

NCT number: NCT05195918
Sponsor: Hal Chapman
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2023-08-24
Primary completion: 2026-03-19
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.